26 août 2022 – The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) will hold an extraordinary meeting on 1 September 2022 to discuss two applications for adapted mRNA Covid-19 vaccines which more closely match the original strain and the BA.1 Omicron subvariant.

For more information, see here.